OVERVIEW

The Global 3D Bioprinting Market is calculated to reach USD 1665.23 million by 2027, growing at a CAGR of 20.23% during the forecast period 2022-2027. The global 3D bioprinting market is expected to experience growth owing to its revolutionary breakthrough in healthcare and pharmaceutical industries. The growing technological advancements, government intervention for improving healthcare, and increasing investments in R&D are also significant factors driving the studied market growth.

TABLE OF CONTENT

• 1 Global 3D Bioprinting Market
  • 1.1 Study Objectives
  • 1.2 Market Definition
  • 1.3 Study Scope
    • 1.3.1 Markets Covered
    • 1.3.2 Geographic Scope

• 2 RESEARCH METHODOLOGY
  • 2.1 Research Data
    • 2.1.1 Secondary Data
      • 2.1.1.1 Key Data From Secondary Sources
    • 2.1.2 Primary Data
      • 2.1.2.1 Key Data From Primary Sources
      • 2.1.2.2 Key Industry Insights
      • 2.1.2.3 Breakdown of Primaries
  • 2.2 Market Size Estimation
    • 2.2.1 Bottom-Up Approach
    • 2.2.2 Top-Down Approach
  • 2.3 Market Breakdown and Data Triangulation
  • 2.4 Research Assumptions

• 3 Global 3D Bioprinting Market ? Executive Summary
  • 3.1 Market Revenue, Market Size and Key Trends by Company
  • 3.2 Key Trends by type of Application
  • 3.3 Key Trends segmented by Geography

• 4 Global 3D Bioprinting Market ? Comparative Analysis
  • 4.1 Product Benchmarking - Top 10 companies
  • 4.2 Top 5 Financials Analysis
  • 4.3 Market Value split by Top 10 companies
  • 4.4 Patent Analysis - Top 10 companies
  • 4.5 Pricing Analysis

• 5 Global 3D Bioprinting Market ? Industry Market Entry Scenario
  • 5.1 Regulatory Framework Overview
  • 5.2 New Business and Ease of Doing business index
  • 5.3 Case studies of successful ventures
  • 5.4 Customer Analysis ? Top 10 companies

• 6 Global 3D Bioprinting Market - Market Forces
  • 6.1 Introduction
  • 6.2 Market Dynamics
    • 6.2.1 Drivers
    • 6.2.2 Challenges
  • 6.3 Porters Analysis of Market
    • 6.3.1 Bargaining power of suppliers
    • 6.3.2 Bargaining powers of customers
    • 6.3.3 Threat of new entrants
    • 6.3.4 Rivalry among existing players
    • 6.3.5 Threat of substitutes

• 7 Global 3D Bioprinting Market - Strategic Analysis
  • 7.1 Value Chain analysis
  • 7.2 Product Life Cycle
  • 7.3 Supplier and distributor analysis (Market share and product dealing strategies)

• 8 Global 3D Bioprinting Market ? By Component (Market Size ? & million/billion)
  • 8.1 3D Bioprinters
  • 8.2 Biomaterials
  • 8.3 Scaffolds

• 9 Global 3D Bioprinting Market - By Technology
  • 9.1 Syringe/Extrusion Bioprinting
  • 9.2 Inkjet Bioprinting
  • 9.3 Magnetic Levitation Bioprinting
  • 9.4 Laser-assisted Bioprinting
  • 9.5 Other

• 10 Global 3D Bioprinting Market - By Application
  • 10.1 Drug Testing and Development
  • 10.2 Regenerative Medicine
  • 10.3 Food Testing
  • 10.4 Research
  • 10.5 Other

• 11 Global 3D Bioprinting Market ? By Geography (Market Size ? & million/billion)
  • 11.1 Introduction
  • 11.2 North America
    • 11.2.1 US
    • 11.2.2 Canada
    • 11.2.3 Mexico
  • 11.3 Europe
    • 11.3.1 U.K
    • 11.3.2 Germany
    • 11.3.3 Italy
    • 11.3.4 France
    • 11.3.5 Spain
    • 11.3.6 Rest of Europe
  • 11.4 Asia-Pacific
    • 11.4.1 China
    • 11.4.2 Japan
    • 11.4.3 India
    • 11.4.4 South Korea
    • 11.4.5 Rest of APAC
  • 11.5 Rest of the World
    • 11.5.1 South America
    • 11.5.2 Middle East
    • 11.5.3 Africa

• 12 Global 3D Bioprinting Market ? Entropy
  • 12.1 New product launches
  • 12.2 M&A's, collaborations, JVs and partnerships13 Global 3D Bioprinting Market Company Profile (Key Players)

• 13 Global 3D Bioprinting Market Company Profile (Key Players)
  • 13.1 Market Share, Company Revenue, Products, M&A, Developments
  • 13.2 Advanced Solutions Life Sciences
  • 13.3 Allevi Inc.
  • 13.4 Envisiontec
  • 13.5 Gesim
  • 13.6 Aspect Biosystems Ltd.
  • 13.7 Cellink
  • 13.8 Nano3D Biosciences, Inc.
  • 13.9 Cyfuse Biomedical K.K.
  • 13.10 Digilab, Inc.
  • 13.11 Poietis
  • 13.12 Company 11 & more

• 14 Global 3D Bioprinting Market - Appendix
  • 14.1 Sources
  • 14.2 Abbreviations